Industry and News Gastrointestinal (GI) Devices Market | Page 2

Aging population is attributed to be one of the major factors in driving the market growth. In
countries such as japan, 50% of population is expected to be above 50 years in the foreseeable
future leading to increase in disease prevalence and higher demand for healthcare facilities.
Gastrointestinal diseases are commonly found in older people and are caused due to improper diet,
food intolerance and digestion among others.
Leading industry participants are expected to raise awareness and educate patients regarding GI
disorders thereby accounting for an increase in market growth. Minimal invasive surgery is another
factor that is expected to increase the demand for these devices. The surgical procedures involves
removal of masses or cancer growths through minimal scarring, shorter surgical time, and low risks.
It also minimizes patient recovery time resulting in reduced cost of hospital stay. For example,
adhesiolysis, gallbladder removal, gastric bypass appendectomy, hernia repair, and colon resection
are surgical procedures that can be performed using a minimally invasive approach. This trend is
expected to increase the market for GI devices used in such procedures.
Improved technology in medical devices market is expected to be another driver for the market
growth. Capital investment in Innovations and R&D are expected to introduce new devices into the
market. Use of Robotic cameras inside the body can simplify the surgical procedures and reduce the
risk of human errors. Suspension of medical device tax in countries such as U.S. anticipated to
attract more investors in the market and thereby increasing the market share.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/gastrointestinal-gi-device-market
Escalating levels of worldwide obesity due to changing lifestyle and food habits, work pressure,
stress, with no time for physical exercises leads to more number of people suffering from obesity.
Obesity is one of the major factor for gastrointestinal disorders. This factor results in high demand in
screening for the diseases driving the procedure volumes.
Major challenge that the market is expected to face is availability of alternative procedures such as
radiation and chemotherapy which can be used for treating esophageal cancer and are known to
have high survival rates than traditional surgery.